Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection
Authors:
- 14 July 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 102 (10) , 1195-1203
Abstract
Background Seroma formation, the most prevalent postoperative complication after mastectomy, is an inflammatory process that is potentially preventable via local steroid administration. This study investigated the effect of local steroid administration on seroma formation. Methods This was a double‐blind randomized placebo‐controlled intervention study of a single dose of 80 mg methylprednisolone versus saline on seroma formation after mastectomy. Patients were further classified according to the surgical axillary procedure: mastectomy with sentinel lymph node biopsy (M + SLNB) or mastectomy with level I–II axillary lymph node dissection (M + ALND). Treatments were administered into the wound cavity via the drain orifice following removal of the drain on the first day after surgery. The primary endpoint was seroma formation; secondary endpoints included the frequency of side‐effects and complications. Results A total of 212 women scheduled for mastectomy for primary breast cancer were included. After M + SLNB, 32 (46 per cent) of 69 women developed a seroma in the methylprednisolone group, compared with 52 (78 per cent) of 67 in the saline group (P < 0·001). The mean cumulative seroma volume in the intention‐to‐treat population for the first 10 and 30 days was significantly lower in the methylprednisolone group (24 ml versus 127 ml in the saline group, and 177 versus 328 ml respectively) (P < 0·001). After M + ALND, similar proportions of patients developed a seroma in the methylprednisolone (35 of 37, 95 per cent) and saline (34 of 36, 94 per cent) groups, and methylprednisolone administration had no significant effect on seroma formation. No differences in infection rate were observed. Conclusion Methylprednisolone administered into the wound cavity on the first day after M + SLNB exerted a highly significant preventive effect against seroma formation during the next 30 days. This effect was not seen in the M + ALND group. Future studies may clarify whether higher or repeated methylprednisolone doses increase the efficacy.Keywords
This publication has 30 references indexed in Scilit:
- The value of mastectomy flap fixation in reducing fluid drainage and seroma formation in breast cancer patientsWorld Journal of Surgical Oncology, 2012
- Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two DecadesJournal of Breast Cancer, 2012
- Preoperative Glucocorticoid Use in Major Abdominal SurgeryAnnals of Surgery, 2011
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancerNature Communications, 2011
- Comparing Scalpel, Electrocautery and Ultrasonic Dissector Effects: The Impact on Wound Complications and Pro-Inflammatory Cytokine Levels in Wound Fluid from Mastectomy PatientsJournal of Breast Cancer, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2009
- Recurrent Postoperative Effusive-Constrictive Pericarditis Associated with Steroid DiscontinuationJournal of Cardiovascular Ultrasound, 2009
- Effects of Locally Applied 5-Fluorouracil on the Prevention of Postmastectomy Seromas in a Rat ModelEuropean Surgical Research, 2007
- The Use of Closed Suction Drainage After Lumpectomy and Axillary Node Dissection for Breast Cancer A Prospective Randomized TrialAnnals of Surgery, 1992